Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5668 of 5804
-
New drug may change how birth control works
Knowledge-focused OngoingThe objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of ethinyl estradiol and levonorgestrel.
Phase: PHASE1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Healthy volunteers help scientists measure drug absorption
Knowledge-focused CompletedThe purpose of this study is to determine in healthy participants the percentage of LY4064809 that enters bloodstream after oral administration. Blood tests will be performed to investigate how the body processes the study drug. For each participant, the study will last about 21 …
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Dentists test which root canal measuring method is more accurate
Knowledge-focused OngoingThis study is designed to compare two commonly used methods for measuring the length of the root canal during root canal treatment. Accurate measurement of the root canal is very important because it helps dentists clean, shape, and fill the canal properly, which improves the suc…
Phase: NA • Sponsor: Dow University of Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Period power: new study reveals how your cycle changes fat digestion
Knowledge-focused Recruiting nowThe goal of this clinical trial is to investigate the effect of menstrual cycle phases on postprandial triglyceride concentrations in healthy young female adults. The main question it aims to answer is: do postprandial triglyceride concentrations differ between the follicular and…
Phase: NA • Sponsor: University of Ottawa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New drug ALXN2230 gets first human safety check
Knowledge-focused Recruiting nowThe primary objective of this study is to evaluate the safety and tolerability of single subcutaneous (SC) doses of ALXN2230 in healthy participants.
Phase: PHASE1 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New questionnaire aims to understand why turkish women get screened for cervical cancer
Knowledge-focused CompletedCervical cancer remains an important public health issue affecting women's health. Cervical cancer screening plays a key role in reducing morbidity and mortality through early detection. Women's decisions to participate in screening are influenced not only by knowledge, but also …
Sponsor: Ankara University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Robot therapist: can a machine help you walk?
Knowledge-focused Recruiting nowRegen is a robot-assisted device designed to help therapists and improve the quality of treatment. It works by replicating the movement of the therapist and providing assistance as needed for the patient. This study aims to assess the safety, feasibility, usability, and ability t…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists track experimental Drug's journey in healthy men
Knowledge-focused Recruiting nowThe main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Study probes seniors' climate health smarts
Knowledge-focused Recruiting nowThe aim of this study is to identify predictors of climate change health literacy in older adults.
Sponsor: Pamukkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New drug TRX-100 takes first step: safety check in healthy people
Knowledge-focused Recruiting nowThis is a Phase 1b, randomized, double-blind, placebo-controlled, dose escalation study of TRX-100 tablets evaluating the safety, pharmacokinetics, and food effect of single ascending doses of TRX-100 in healthy volunteers.
Phase: PHASE1 • Sponsor: Traws Pharma, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Parkinson's drug WD-1603: does timing matter?
Knowledge-focused Recruiting nowWD-1603 contains two different drugs called levodopa and carbidopa in one tablet. The goal of this clinical trial is to see if taking the study drug WD-1603 at different time intervals affects how the drug acts in healthy volunteers. We also want to learn about the safety of WD-1…
Phase: PHASE1 • Sponsor: Shanghai WD Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Healthy volunteers help test simpler injection for mirikizumab
Knowledge-focused Recruiting nowThe main purpose of this study is to assess the safety and tolerability of mirikizumab (LY3074828) solution formulation administered as a single injection compared with two injections under the skin in healthy participants. Blood tests will be performed to investigate how the bod…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Generic selegiline patch put to the test in healthy volunteers
Knowledge-focused CompletedThe purpose of this research study is to compare the bioavailability and adhesion of a generic Selegiline transdermal system (TDS) against the marketed comparator (EMSAM®) in healthy volunteers. Systemic and local safety and tolerability will be also observed and evaluated.
Phase: PHASE1 • Sponsor: Corium Innovations, Inc. • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Tafamidis tablet vs capsule: which works better?
Knowledge-focused TerminatedThe purpose of this clinical trial is to compare the amount of tafamidis in the blood of healthy adult participants after taking two different forms of tafamidis by mouth under fed conditions.
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
New drug IY-828026 tested in healthy people for first time
Knowledge-focused Recruiting nowA randomized, double-blinded, partial-open, placebo/active-controlled, single/multiple dosing, dose escalation phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of IY-828026 in healthy adult volunteers
Phase: PHASE1 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New drug ME3241 enters first human safety tests
Knowledge-focused Recruiting nowA Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants
Phase: PHASE1 • Sponsor: Meiji Pharma USA Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Healthy volunteers help test enlicitide absorption
Knowledge-focused CompletedThe goal of this study is to learn what happens to enlicitide (MK-0616) in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of enlicitide and if people tolerate it.
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Drug interaction study launches: will BV100 change how polymyxin b works?
Knowledge-focused Recruiting nowThis is an open-label, fixed sequence Phase I clinical study to evaluate the effect of multiple doses of BV100 on the PK of polymyxin B in healthy participants (HPs).
Phase: PHASE1 • Sponsor: BioVersys SAS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New drug HSK55879 enters first human safety trial
Knowledge-focused Recruiting nowThis is a single-center, random, double blind, placebo control clinical study to evaluate the safety, tolerability pharmacokinetics and food effect of HSK55879 in healthy subjects
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Tiny study tracks experimental schizophrenia Drug's journey in healthy men
Knowledge-focused Not yet recruitingThe purpose of the present trial is to obtain information on the absorption, distribution, metabolism, excretion and pharmacokinetics (PK) of 14C-SEP-380135 and its metabolites following a single oral dose.
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC